Transbronchial Biopsies With Cryoprobe in Patients With Lung Transplantation.
NCT03090581 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2017-03-29
Summary
The survival of lung transplant patients (PD) is limited mainly by Infections, graft dysfunction in the immediate postoperative period and chronic dysfunction. Up to 36% have an episode of acute rejection after transplantation. For the diagnosis of these pathologies, transbronchial lung biopsy (BPTB) is essential. The classical method is the realization of BPTB with conventional clamp, but the performance diagnosis is limited. However, the use of cryoprobes for sampling in other pulmonary pathologies have been shown to achieve a higher diagnostic yield. The BPTB performance is variable and depends on factors such as sample size and the presence of artifacts (crushing) produced by the forceps tweezers. The objective principal is to compare the diagnostic yield of samples obtained with cryoprobe compared to those obtained with conventional biopsy tweezers. A prospective, randomized, and comparative study is proposed for all patients in the intensive care unit after lung transplantation in a 24-month period, at Vall de Hebron Hospital. Patients will be divided into two groups: symptomatic and asymptomatic. The exclusion criteria are the contraindications of the procedure and the factors which increase the hemorrhagic risk. A flexible bronchoscope (BF-18BS) will be used and the procedure will be performed according to the technique conventional. The patient undergoing the procedure will be intubated, sedated and relaxed under supervision and continuous monitoring by an intensivist. A bronchoalveolar lavage and a maximum of 6 samples will be obtained. Morphological study (middle area, artifacts, components, diagnosis), microbiological, histological and anatomopathological according to the usual protocol. The duration of the procedure, the complications and the frequency with which the diagnosis obtained after the procedure modifies the therapeutic behavior will be monitored. These data will allow to evaluate the potential benefits of this procedure in the diagnosis of pulmonary pathology in lung transplantation.
Conditions
- Lung Transplant Rejection
Interventions
- PROCEDURE
-
Biopsies CP
Transbronchial biopsies will be obtained with a flexible bronchoscope, using a cryoprobe.
- PROCEDURE
-
Biopsies FC
Transbronchial biopsies will be obtained with a flexible bronchoscope, using a forceps.
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Principal Investigators
-
Javier De Gracia, Pneumologist · Respiratory department
-
Karina I Loor, MD · Respiratory department
-
Mario Culebras, MD · Respiratory department
-
Antonio Álvarez, MD · Respiratory department
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-03-15
- Primary Completion
- 2018-01-31
- Completion
- 2018-03-31
Countries
- Spain
Study Locations
More Related Trials
-
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
NCT07134491 ·Status: RECRUITING
-
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
NCT07046910 ·Status: RECRUITING ·Phase: PHASE2
-
Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant
NCT03697395 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation
NCT00558597 ·Status: UNKNOWN
-
Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation
NCT02294097 ·Status: UNKNOWN ·Phase: NA
-
DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection
NCT03702257 ·Status: RECRUITING ·Phase: NA
-
Comparison of Coronary CT Angiography With Conventional Coronary Angiography in Liver and Lung Transplant Candidates
NCT00727051 ·Status: WITHDRAWN
-
T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation
NCT03587493 ·Status: UNKNOWN ·Phase: NA
-
Sleep Disordered Breathing and Lung Transplantation
NCT01179087 ·Status: UNKNOWN
-
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
NCT03987113 ·Status: COMPLETED
-
Protocol Biopsies in High-risk Renal Transplant Recipients
NCT04154267 ·Status: UNKNOWN ·Phase: NA
-
Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation
NCT06734013 ·Status: RECRUITING ·Phase: NA
-
10°C vs 4°C Lung Preservation RCT
NCT05898776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Rejection Diagnosis in Kidney Transplants Patients
NCT03582436 ·Status: COMPLETED
-
Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies
NCT05306795 ·Status: UNKNOWN
-
MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)
NCT05184426 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
NCT04837339 ·Status: RECRUITING ·Phase: NA
-
B Cell Lymphocyte in Humoral Rejection and Alloimmunisation
NCT03016455 ·Status: UNKNOWN
-
Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants
NCT01982903 ·Status: UNKNOWN
-
Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
NCT02782416 ·Status: UNKNOWN ·Phase: NA
-
Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)
NCT04377139 ·Status: UNKNOWN
-
Prospective, Single-Arm, Study to Assess the Safety and Performance of the TB1-K Device for Organ Preservation in Donor Kidneys for Transplantation
NCT03600285 ·Status: UNKNOWN ·Phase: NA
-
HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients
NCT05550662 ·Status: TERMINATED ·Phase: PHASE2
-
Histologic Evolution of Patients With Liver Transplantation
NCT06103097 ·Status: RECRUITING
-
Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
NCT04702022 ·Status: RECRUITING ·Phase: NA